Interpretation of Hemoadsorption:Consensus Report of the 30th Acute Disease Quality Initiative Workgroup
This article aims to interpret the consensus report of the 30th Acute Disease Quality Initiative(ADQI)workgroup on hemoadsorption(HA)technology,providing reference for clinical practice and research.HA has shown therapeutic advantages in various diseases.The ADQI workgroup assessed the research progress of HA technology,confirming its clinically acceptable short-term biocompatibility,safety,and technical feasibility,as well as experimental demonstration of specified target molecule removal.Preliminary studies have shown a potential benefit of endotoxin-based HA in sepsis.However,due to insufficient clinical evidence,HA is still considered an experimental intervention.The ADQI consensus report focuses on filling existing knowledge gaps,pointing out future research directions,and providing important guidance for the clinical application and further research of HA technology.
NETL
NSTL
万方数据
